CD44 and breast cancer: Phillips et al. demonstrated that the breast cancer MCF7 cells with CD44+CD24− phenotype were relatively resistant to radiotherapy, generating less ROS and had decreased DNA damage in response to radiation, leading to increased cancer cell number after short courses of fractionated irradiation [94].